Good MorningEquities rebounded again on Wednesday gaining about 2.0% at the height of the session. The move was driven by better than expected data on the labor front as well as some less-hawkish than expected comments from Jerome Powell. On the labor front, the ADP employment report showed the addition of more than 1.0 million new jobs to the economy when adjusted for revisions. The data is more than double the expectations and points to even tighter labor market conditions than previously thought. The NFP is due out on Friday and could reveal the same information. The risk with the NFP is that wage gains are expected to top 6.0% on a YOY basis and drive consumer-level inflation this year.
Elsewhere in the markets, the price of West Texas Intermediate surged more than 3.0% on Wednesday to above $113 per barrel. This is the highest level for WTI in over a decade and prices are expected to keep rising. Based on the technical outlook, the price of WTI will move above $120 very soon and will be another driving force of inflation this year. Featured: 25 candidates screened. 5 made it. (Ad) 
|
Technology | | The Analysts Still Love Salesforce.com
The analysts still love Salesforce.com (NYSE: CRM) despite the round of price target reductions it just received. The company reported a stellar quarter and raised its guidance but the analyst still felt the need to adjust their targets. The takeaway is that, ... Read the Full Story |
|
From Our Partners | | A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. | | See the ticker behind this Grand Canyon energy breakthrough now |
|
Consumer Discretionary | |
The United States is more than 5,000 miles away from Ukraine. American companies derive very little revenue from Ukraine. Some have exposure to Russia—albeit to a rapidly dwindling extent as world governments, corporations, and sports organizations continue to denounce the country’s at... Read the Full Story |
|
Consumer Discretionary | |
These Quality Dividend-Paying Stocks Are Worth a Look in March
As we move into the month of March, dividend stocks remain some of the strongest options to consider in the current market environment. Whether you are concerned about the impacts of inflation or simply want to own stocks that are kno... Read the Full Story |
|
From Our Partners | | Tobacco, telecom, pipelines, and healthcare real estate trade at 10 to 15 times earnings while the index yields about 1 percent.
A free report highlights seven cash-generating stocks with a 5 percent forward yield floor and roughly 6.5 percent average cash yield, capped at two picks per sector.
Each pick includes coverage numbers and an honest bear case. Five of the seven have raised payouts for 17 to 56 straight years. | | Get the seven high-yield dividend stocks free now |
|
Markets | | Visual social media lifestyle brand platform Pinterest (NYSE: PINS) stock has fallen over (-60%) off its pandemic highs of $90.09. To the disappointment of investors, the Company experienced a (-6%) drop in monthly active users (MAUs) despite having 431 million worldwide users in Q4 2021. While Pint... Read the Full Story |
|
Consumer Discretionary | |
The Ross Stores Outlook Just Got 20% Brighter
Shares of Ross Stores (NASDAQ: ROST) are moving up because of a combination of factors that include performance, capital returns, and a greatly improved outlook for long-term growth. The company says that, due to changes within the industry, they are... Read the Full Story |
|
From Our Partners | | Matt Monaco started with a $2,000 trading account and no clear strategy. After two years of trial and error, he crossed $1 million in 2020.
Today his account sits at $3 million, generating roughly $100,000 a month using a repeatable system he calls The Income Blueprint.
He's revealing the exact five-step scan and three trading lanes behind it in a free live training. | | Reserve your seat and claim The Income Blueprint free |
|
Consumer Discretionary | |
Each year, Americans chuck millions of tons of textiles into landfills. As these discarded remnants decompose, they release methane, dyes and chemicals, which pollute the air and contaminate groundwater and soil. Who knew that throwing out a ratty T-shirt could have major effects on the planet?
R... Read the Full Story |
|
Technology | |
These companies are positioned to build on the tepid recovery in chip stocks
It’s been almost a week since Russia invaded Ukraine and the conflict continues to take a toll on U.S. equity markets. Semiconductor companies are among the latest to ban sales to Russia.
The significance of th... Read the Full Story |
|
Consumer Staples | |
Hormel Rockets Higher On Record Results
The institutions have been buying Hormel (NYSE: HRL) and we are not surprised by the news. The institutions have been shifting their attention to blue chips and dividends including Consumer Staples and we see that trend continuing for the foreseeable futur... Read the Full Story |
|
Finance | |
With its stock trading close to all-time lows, crypto exchange Coinbase (NASDAQ: COIN) released their Q4 earnings last week to a curious Wall Street. At first glance, they made for good reading. Analysts had been expecting their EPS to come in at $1.89, but they delivered a 75% beat on that with a... Read the Full Story |
|
Industrials | |
The Best Offense is a Good Defense
Geopolitical events like the current conflict between Russia and Ukraine can cause some big moves in financial markets, which is evident in the price action investors have witnessed over the last few days. Commodity prices have been soaring, equity markets have ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It also developing Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating Myelodysplastic Neoplasms, as well as verdinexor, KPT-9274, and IL-12 compounds. The company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, it has a collaboration with Bristol Myers Squibb company to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed/refractory multiple myeloma. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts. | | View Today's Stock Pick |
|
